The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 5
- 5 new
- Median first-year cost
- $13,829,118
- $83,578,996 in all
- Institutions
- 5
- 5 contact PIs
- Patents
- 1
- from 1 funded project
Awards by fiscal year
Fiscal years 2014 to 2026.
Most frequent institutions
- BRIGHAM AND WOMEN'S HOSPITAL1
- CHILDREN'S HOSP OF PHILADELPHIA1
- ECOG-ACRIN MEDICAL RESEARCH FOUNDATION1
- NRG ONCOLOGY FOUNDATION, INC.1
- OREGON HEALTH & SCIENCE UNIVERSITY1
Most frequent study sections
- Special Emphasis Panel (ZCA1 GRB-I (O1))5
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2014 | COG NCTN Network Group Operations Center1U10CA180886-01 | Adamson, Peter C. | CHILDREN'S HOSP OF PHILADELPHIA, PA | First-year cost $26,616,497 | Study section ZCA1 |
| FY2014 | NRG ONCOLOGY NETWORK GROUP OPERATIONS CENTER1U10CA180868-01 | Curran, Walter J.Disaia, Philip J.Wolmark, Norman | NRG ONCOLOGY FOUNDATION, INC., PA | First-year cost $18,813,807 | Study section ZCA1 |
| FY2014 | SWOG Network Group Operations Center of the NCTN1U10CA180888-01 | Blanke, Charles D.Ellis, Lee M.Schott, Anne F | OREGON HEALTH & SCIENCE UNIVERSITY, OR | First-year cost $13,829,118 | Study section ZCA1 |
| FY2014 | ECOG-ACRIN Operations Center1U10CA180820-01 | Comis, Robert LSchnall, Mitchell D. | ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, PA | First-year cost $13,778,655 | Study section ZCA1 |
| FY2014 | Alliance for Clinical Trials in Oncology Operations Center1U10CA180821-01 | Bertagnolli, Monica MFleming, Gini F.Perez, Edith A. | BRIGHAM AND WOMEN'S HOSPITAL, MA | First-year cost $10,540,919 | Study section ZCA1 |
Patents from its funded projects
1 patent names 1 of the 5 funded projects.
- US 11,028,448 (opens the patent at USPTO, a PDF, in a new tab)METHODS OF IDENTIFYING RISK OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) PATHWAY INHIBITOR-INDUCED HYPERTENSIONGranted June 8, 2021 to THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL and Duke UniversityU10CA180821 · BRIGHAM AND WOMEN'S HOSPITAL, MA
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-13-0.3.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.